Overview

Gender

male

Investor Type

Investment Partner

Anil Achyuta is the Director of External Innovation at L’Oréal, where he invests in next-generation technologies in materials science, digital / skin health, and medical aesthetics. Previously, Anil advised GlaxoSmithKline's (GSK) Bioelectronics R&D division and their Venture Arm – Action Potential Ventures (APVC) as their Associate Consulting Director (now a $750M joint venture between GSK and Google’s Verily). Anil also created, led, and launched GSK's $1M Innovation Challenge, an open global competition. The Innovation Challenge catalyzed several strategic privatepublic partnerships and was designed to closely complement President Obama's BRAIN Initiative.

Before GSK, Anil worked at Draper’s Business Development leading strategic projects in lab-on-a-chip, tissue engineering, and implantable devices. In lab-on-a-chip devices arena, Anil co-led the liver and brain-on-a-chip concepts, where his team showed malarial infections inside the liver chip (Gates foundation funded project). For his technical and business achievements, Anil won the Outstanding Contributor of the Year award at Draper for three consecutive years in a row along with "Neuroengineering Contributor of the Year" in 2012 by Lab-on-a-chip, a top micro-device engineering journal.

Anil holds a Ph.D. in Chemical Engineering and an M.B.A along with a Certificate in Venture Capital and Private Equity from Harvard Business School Executive Education. Anil also actively mentors over 3 start-ups in various areas and helps entrepreneurs in financing, product development, and business development strategy.